Robert Maciel Associates LLC (RMA) an American medical software company, provides custom maternal serum screening software to diagnostic laboratories worldwide. We partner with medical and healthcare systems to foster and advocate for women’s reproductive health.
In 1984, RMA introduced its Maciel Prenatal Interpreter custom software, the first commercial prenatal screening software available in the world. MPI provides a maternal serum screen assessment of fetuses at risk for Down syndrome, trisomy 18, trisomy 13, open neural tube defects, and Smith-Lemli-Opitz Syndrome (SLOS). MPI complies with CAP standards.
MPI has been in continuous use and development since the beginnings of both personal computers and prenatal screening. We take scrupulous care in implementing each component so that it meets the highest standards of accuracy. In many cases we have collaborated with the individuals who originated prenatal screening techniques to ensure the quality of our software. MPI has been the system of choice for over 575 prenatal programs in more than 35 countries, and a dozen state-run programs in the USA. Our long-standing clients include:
- Medical universities throughout the world
- Well-known large-volume laboratories
- Nationally recognized hospitals of excellence
- International pharmaceutical companies
The American College of Obstetricians and Gynecologists recommends that women, regardless of maternal age, be offered prenatal assessment for aneuploidy either by screening or invasive prenatal diagnosis regardless of maternal age.